GB202117366D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB202117366D0
GB202117366D0 GBGB2117366.1A GB202117366A GB202117366D0 GB 202117366 D0 GB202117366 D0 GB 202117366D0 GB 202117366 A GB202117366 A GB 202117366A GB 202117366 D0 GB202117366 D0 GB 202117366D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2117366.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mission Therapeutics Ltd
Original Assignee
Mission Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mission Therapeutics Ltd filed Critical Mission Therapeutics Ltd
Priority to GBGB2117366.1A priority Critical patent/GB202117366D0/en
Publication of GB202117366D0 publication Critical patent/GB202117366D0/en
Priority to PCT/EP2022/083842 priority patent/WO2023099561A1/en
Ceased legal-status Critical Current

Links

GBGB2117366.1A 2021-12-01 2021-12-01 Novel compounds Ceased GB202117366D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2117366.1A GB202117366D0 (en) 2021-12-01 2021-12-01 Novel compounds
PCT/EP2022/083842 WO2023099561A1 (en) 2021-12-01 2022-11-30 Substituted n-cyanopyrrolidines with activity as usp30 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2117366.1A GB202117366D0 (en) 2021-12-01 2021-12-01 Novel compounds

Publications (1)

Publication Number Publication Date
GB202117366D0 true GB202117366D0 (en) 2022-01-12

Family

ID=80038433

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2117366.1A Ceased GB202117366D0 (en) 2021-12-01 2021-12-01 Novel compounds

Country Status (1)

Country Link
GB (1) GB202117366D0 (en)

Similar Documents

Publication Publication Date Title
GB2605894B (en) Novel compounds
GB202008749D0 (en) Novel compounds
GB202101734D0 (en) Novel Compounds
GB202115158D0 (en) Novel compounds
GB202016800D0 (en) Novel compounds
IL312389A (en) Novel benzyltryptamine compounds
GB202118096D0 (en) Novel compounds
GB202117608D0 (en) Novel compounds
GB202117366D0 (en) Novel compounds
GB202115156D0 (en) Novel compounds
GB202115150D0 (en) Novel compounds
GB202113016D0 (en) Novel compounds
GB202110809D0 (en) Novel compounds
GB202109446D0 (en) Novel compounds
GB202108873D0 (en) Novel compounds
GB202106872D0 (en) Novel compounds
GB202106871D0 (en) Novel compounds
GB202101935D0 (en) Novel compounds
GB202101573D0 (en) Novel compounds
GB202101280D0 (en) Novel compounds
GB202019590D0 (en) Novel Compounds
GB202019588D0 (en) Novel Compounds
GB202016785D0 (en) Novel compounds
GB202016758D0 (en) Novel compounds
GB202016791D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)